A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

NCT04204161 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood
Refractory B-cell Acute Lymphoblastic Leukemia, Childhood
Relapsed/Refractory B-cell Lymphoma, Childhood

Interventions

BIOLOGICAL: CAR-T19/CAR-T22

Sponsor

Shenzhen BinDeBio Ltd.

Collaborators

[object Object]